Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Spine Biologics Market, By Product
7.1. Spine Biologics Market, By Product, 2021-2028
7.1.1. Spinal Allografts
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Bone Graft Substitutes
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Cell-based Matrix
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Spine Biologics Market, By End-use
8.1. Spine Biologics Market, By End-use, 2021-2028
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Ambulatory Surgical Centers
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Spine Biologics Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Product (2016-2028)
9.1.2. Market Revenue and Forecast, By End-use (2016-2028)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.1.3.2. Market Revenue and Forecast, By End-use (2016-2028)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.1.4.2. Market Revenue and Forecast, By End-use (2016-2028)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.2. Market Revenue and Forecast, By End-use (2016-2028)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.3.2. Market Revenue and Forecast, By End-use (2016-2028)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.4.2. Market Revenue and Forecast, By End-use (2016-2028)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.5.2. Market Revenue and Forecast, By End-use (2016-2028)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Product (2016-2028)
9.2.6.2. Market Revenue and Forecast, By End-use (2016-2028)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.2. Market Revenue and Forecast, By End-use (2016-2028)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.3.2. Market Revenue and Forecast, By End-use (2016-2028)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.4.2. Market Revenue and Forecast, By End-use (2016-2028)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.5.2. Market Revenue and Forecast, By End-use (2016-2028)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Product (2016-2028)
9.3.6.2. Market Revenue and Forecast, By End-use (2016-2028)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.2. Market Revenue and Forecast, By End-use (2016-2028)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.3.2. Market Revenue and Forecast, By End-use (2016-2028)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.4.2. Market Revenue and Forecast, By End-use (2016-2028)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.5.2. Market Revenue and Forecast, By End-use (2016-2028)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Product (2016-2028)
9.4.6.2. Market Revenue and Forecast, By End-use (2016-2028)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Product (2016-2028)
9.5.2. Market Revenue and Forecast, By End-use (2016-2028)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Product (2016-2028)
9.5.3.2. Market Revenue and Forecast, By End-use (2016-2028)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Product (2016-2028)
9.5.4.2. Market Revenue and Forecast, By End-use (2016-2028)
Chapter 10. Company Profiles
10.1. Stryker
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Orthofix Holdings, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. NuVasive, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. K2M Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. DePuy Synthes
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Wright Medical Group N.V.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Exactech, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Zimmer Biomet
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Arthrex, Inc.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Medtronic Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Organogenesis
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Lattice Biologics Ltd.
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms